Partnering with Orphalan
Collaboration for rare disease advancement
At Orphalan, we believe that collaboration is essential to advancing rare disease treatment and improving patient outcomes. We partner with healthcare professionals, researchers, institutions and organisations worldwide.
Building Partnerships That Matter
We collaborate with healthcare professionals, researchers, institutions and organisations worldwide to advance rare disease treatment and improve outcomes for patients.
Unrestricted Educational Grants
Support for independent medical education initiatives that advance rare disease understanding and treatment
Research Collaborations
Partnerships with academic institutions and research organisations to advance rare disease science
Commercial Partnerships
Business development, licensing and strategic partnerships to expand patient access worldwide.
Unrestricted Educational Grants
Orphalan provides unrestricted educational grants to support independent medical education initiatives that enhance healthcare professionals' understanding of rare diseases and their treatment.
These grants enable the development of educational programs, conferences and resources that benefit the rare disease community. Grant recipients maintain full independence in developing and delivering their educational activities, ensuring objective, unbiased and scientifically sound medical education.
Grant Objectives
- Advance medical education in rare disease diagnosis and treatment
- Support evidence-based educational programs for healthcare professionals
- Promote awareness and understanding of rare diseases within the medical community
- Foster collaboration between healthcare professionals, researchers and patient advocacy groups
Eligibility
Grants are available to accredited medical education providers, professional medical societies, academic institutions and non-profit organisations with expertise in rare disease education. All applications are evaluated based on educational merit, scientific rigor and alignment with Orphalan's commitment to improving patient outcomes.
Investigator-Initiated Research (IIR)
Our IIR programme supports independent research initiatives in rare diseases. We partner with researchers worldwide to advance scientific understanding and improve clinical outcomes for patients.
Through our IIR programme, we provide funding, product supply and scientific collaboration to support high-quality, investigator-led research that addresses important questions in rare disease treatment.
Learn More About IIR
Commercial Partnerships
Business development, licensing and strategic partnerships to expand patient access worldwide.
Business Development
Orphalan has built its own sales and marketing functions in Europe and the US. We are an experienced team with clinical development, regulatory, market access and a track record of commercialisation in rare disease.
We have local medical experts and commercial teams in our key markets, and we work with partners in all other regions where our product is available.
Partner with Orphalan
At Orphalan we are committed to expanding our knowledge base and building a pipeline of innovative therapies for people living with rare diseases. We work with a range of institutional or private partners, building relationships that lead to:
- Acquisitions
- Joint ventures
- Product licensing
- Other partnership models
Start a Conversation
Interested in partnering with Orphalan? We welcome inquiries from organisations and individuals committed to advancing rare disease treatment. Reach out and let us explore how we can work together.
Get in Touch